Trial · NCT00818389
Adverse events122
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 122
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anorexia | Gastrointestinal disorders | Lithium + Riluzole | 6 | 40 | 7 |
| other | Anorexia | Gastrointestinal disorders | Placebo + Riluzole | 2 | 44 | 4 |
| other | Bruising (in absence of grade 3 or 4 thrombocytopenia) | Blood and lymphatic system disorders | Lithium + Riluzole | 5 | 40 | 7 |
| other | Bruising (in absence of grade 3 or 4 thrombocytopenia) | Blood and lymphatic system disorders | Placebo + Riluzole | 1 | 44 | 2 |
| other | Chest congestion | Respiratory, thoracic and mediastinal disorders | Lithium + Riluzole | 6 | 40 | 8 |
| other | Chest congestion | Respiratory, thoracic and mediastinal disorders | Placebo + Riluzole | 5 | 44 | 5 |
| other | Constipation | Gastrointestinal disorders | Lithium + Riluzole | 5 | 40 | 7 |
| other | Constipation | Gastrointestinal disorders | Placebo + Riluzole | 8 | 44 | 9 |
| other | Depression | Psychiatric disorders | Lithium + Riluzole | 6 | 40 | 9 |
| other | Depression | Psychiatric disorders | Placebo + Riluzole | 4 | 44 | 6 |
| other | Diarrhea | Gastrointestinal disorders | Lithium + Riluzole | 5 | 40 | 5 |
| other | Diarrhea | Gastrointestinal disorders | Placebo + Riluzole | 5 | 44 | 6 |
| other | Dizziness | Nervous system disorders | Lithium + Riluzole | 5 | 40 | 6 |
| other | Dizziness | Nervous system disorders | Placebo + Riluzole | 1 | 44 | 1 |
| other | Drooling | Gastrointestinal disorders | Lithium + Riluzole | 7 | 40 | 7 |
| other | Drooling | Gastrointestinal disorders | Placebo + Riluzole | 6 | 44 | 7 |
| other | Dysarthria/voice changes | Nervous system disorders | Lithium + Riluzole | 7 | 40 | 7 |
| other | Dysarthria/voice changes | Nervous system disorders | Placebo + Riluzole | 4 | 44 | 5 |
| other | Dysphagia (difficulty swallowing) | Nervous system disorders | Lithium + Riluzole | 6 | 40 | 9 |
| other | Dysphagia (difficulty swallowing) | Nervous system disorders | Placebo + Riluzole | 9 | 44 | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00818389/events